Sprüssel, A.; Suzuki, T.; Miyata, N.; Astrahantseff, K.; Szymansky, A.; Toedling, J.; Thole-Kliesch, T.M.; Ballagee, A.; Lodrini, M.; Künkele, A.;
et al. Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis. J. Clin. Med. 2024, 13, 6081.
https://doi.org/10.3390/jcm13206081
AMA Style
Sprüssel A, Suzuki T, Miyata N, Astrahantseff K, Szymansky A, Toedling J, Thole-Kliesch TM, Ballagee A, Lodrini M, Künkele A,
et al. Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis. Journal of Clinical Medicine. 2024; 13(20):6081.
https://doi.org/10.3390/jcm13206081
Chicago/Turabian Style
Sprüssel, Annika, Takayoshi Suzuki, Naoki Miyata, Kathy Astrahantseff, Annabell Szymansky, Joern Toedling, Theresa M. Thole-Kliesch, Annika Ballagee, Marco Lodrini, Annette Künkele,
and et al. 2024. "Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis" Journal of Clinical Medicine 13, no. 20: 6081.
https://doi.org/10.3390/jcm13206081
APA Style
Sprüssel, A., Suzuki, T., Miyata, N., Astrahantseff, K., Szymansky, A., Toedling, J., Thole-Kliesch, T. M., Ballagee, A., Lodrini, M., Künkele, A., Truss, M., Heukamp, L. C., Mathia, S., Hertwig, F., Rosenberger, C., Eggert, A., Deubzer, H. E., & Schulte, J. H.
(2024). Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis. Journal of Clinical Medicine, 13(20), 6081.
https://doi.org/10.3390/jcm13206081
